Introduction
============

Age-related changes in cerebral blood flow (CBF) have been related to increased risk for cognitive decline and Alzheimer disease (AD), implying that cerebrovascular mechanisms play a pivotal role in brain health and sustenance of cognition ([@B43]; [@B29]; [@B31]; [@B36]). For the past three decades, the nuclear medicine techniques Single Photon Emission Computed Tomography (SPECT) and Positron Emission Tomography (PET) have served as gold standards for perfusion and metabolism studies in brain aging and AD. These techniques, however, require use of radioactive tracers and are more expensive that the more recently developed perfusion-weighted MRI techniques. Among these latter, arterial spin labeling (ASL) uses magnetically labeled arterial blood water as a diffusible endogenous tracer and displays similar diagnostic ability to detect AD as fluoro-2-deoxy-D-glucose (FDG)-PET ([@B39]). This technique revealed brain hypoperfusion mainly in bilateral parietal areas, precuneus, angular and posterior cingulate cortex in MCI and early AD, which overlaps with the patterns of hypometabolism on FDG-PET observed later in disease progression, indicating the potential to use ASL for early detection of cognitive decline (for review see [@B1]; [@B12]; [@B21]; [@B17]; [@B34]). The rare ASL studies showed a more diffuse hypoperfusion in posterior inferior and frontal aspects of the brain in at risk healthy controls ([@B39]; [@B14]). Higher ASL measured-CBF in medial frontal, lateral temporal, parietal cortex, insula, and basal ganglia was reported in APOE 𝜀4 carriers with the worst cognitive performances ([@B48]).

The capacity of brain vasculature to enhance blood flow in response to challenging conditions is found to be a key parameter in very early stages of neurodegeneration, even prior to the development of clinically overt cognitive deficits. In fact, higher ASL values in these cases may be the consequence of the brain vasculature's efforts of adapting to a threatening cellular environment. Blood oxygenation level dependent (BOLD) functional MRI allows for assessment of this reactivity. Recent data has indicated that the cerebral vasoreactivity CO~2~ (CVR CO~2~) could detect significant dysfunctions both in MCI and AD cases. In contrast, whether or not similar changes occur in at risk healthy elders is still unknown ([@B11]; [@B45]; [@B33]).

Within this study, both ASL perfusion and CVR CO~2~ patterns were explored in 79 community-dwelling elderly individuals who were cognitively preserved at inclusion and had undergone two neuropsychological assessments during a subsequent 3-year period. The data revealed distinct patterns of brain perfusion and cerebrovascular reactivity as a function of the cognitive trajectories of elderly controls.

Materials and Methods {#s1}
=====================

Participants
------------

The series used in our analysis is part of a population-based longitudinal study on healthy aging funded by the Swiss National Foundation of Research in Geneva. The research protocol was approved by the Ethics Committee of the University Hospitals of Geneva. All experimental procedures were carried out in accordance with the approved guidelines and with the principles of the Declaration of Helsinki. All participants were given written informed consent prior to inclusion. Participants were contacted via advertisements in local media to guarantee a community-based sample. Exclusion criteria included psychiatric or neurologic disorders, sustained head injury, history of major medical disorders (neoplasm or cardiac illness), alcohol or drug abuse, regular use of neuroleptics, antidepressants or psychostimulants and contraindications to MR imaging. To eliminate possible confounding effects of cardiovascular disease, individuals with subtle cardiovascular symptoms and a history of stroke and transient ischemic episodes were also excluded from the present study.

The final sample included 79 participants, classified as cognitively healthy controls (mean age 78.7 ± 3.5 years; 44 women) who underwent three neuropsychological evaluations (baseline 18 months and 36 months follow-up) and a MRI-T1 examination (only baseline). Clinical assessment included the Mini-Mental State Examination (MMSE, [@B19]), the Lawton Instrumental Activities of Daily Living (IADL, [@B7]) and the Hospital Anxiety and Depression Scale (HAD, [@B47]), the Consortium to Establish a Registry for Alzheimer's Disease (CERAD) neuropsychological battery, Digit Span ([@B41]) and Corsi block ([@B28]) for verbal and visual working memory respectively, the Trail Making Test A and B ([@B32]) for executive functioning, Digit-Symbol-Coding ([@B42]) for attention, Boston Naming ([@B25]) for language, Ghent Overlapping Figures ([@B35]) for visual gnosis and RI-48 Cued Recall Test (RI-48) for episodic memory ([@B20]). Individuals meeting the DSM-IV criteria of dementia or for MCI on the basis of clinical and neuropsychological assessments, were excluded from the study ([@B20]). In order to explore correlations between the neuropsychological performances and imaging variables, and given the limited sample size, we selected two main tests that encompass visual working memory (Shapes test, [@B6]) and executive functions (Phonemic verbal fluency [@B10]). Descriptive statistics and statistical differences between the SS, V, and PP group on age, gender and the neuropsychological scores were calculated with separate one-way ANOVA's using IBM SPSS Statistics version 25.

Neuropsychological Follow-Up
----------------------------

For follow-up measurements, which took place 18 months after inclusion, the cognitively healthy individuals underwent full neuropsychological assessment once again. Individuals who obtained stable cognitive scores over the baseline and follow-up evaluation were classified as stable controls. The progressive control group obtained a follow-up evaluation of at least 0.5 standard deviations (SD) lower than measured at baseline, on a minimum of two cognitive tests. Two neuropsychologists clinically assessed all individuals independently. The final classification was determined by a trained neuropsychologist taking into account both the results of the neuropsychological tests and overall clinical assessment ([@B44]). All of the cases were assessed once again 18 months later with the same neuropsychological battery. The participants were subsequently grouped as described above (−0.5 SD in at least two cognitive tests), with comparison of the scores of the latest assessment. Stable individuals showing no changes in the second assessment were classified in the stable-stable (SS) group and progressive individuals demonstrating a further decline as progressive-progressive (PP). The variable group (V) refers to participants demonstrating a fluctuating scoring pattern, incorporating stable-progressive, progressive-stable or progressive-improved individuals. The final sample included 24 SS, 33 V, and 22 PP cases.

ASL
---

### MR Imaging

As described previously in more detail ([@B40]), ASL imaging was performed on a 3T GE MR750w using a 32-channel head array coil. Perfusion images were acquired with a 3D stack-of-spiral fast spin echo sequence preceded by a Hadamard encoded Pseudo-Continuous ASL (PCASL) module with background suppression. A total label duration of 4 s. was encoded into seven sub-blocks. The label durations were 0.22, 0.26, 0.30, 0.37, 0.48, 0.68, and 1.18 s, post label delays were chosen to be 1.00, 1.22, 1.48, 1.78, 2.15, 2.62, and 3.32 s. The total scan time lasted for 4.02 min.

Images were created at all delay times. The combined delay map consists of the sum of the delay times per subject. Two CBF maps were used for subsequent analysis, the raw uncorrected flow maps and the transit time corrected flow maps adjusted for arterial transit time.

Key imaging parameters were: field of view (FOV) = 22.0 cm, slice thickness 4.0 mm, 32 slices, bandwidth ± 62.5 kHz, 4 arms with 640 points each. The PCASL images had a matrix size of 128 × 128 and a voxel size of 1.88 × 1.88 × 4.0. Images were acquired with an echo time of 10.5 ms and a repetition time of 5936 ms. Acquisition included a T1/PD weighted reference image with matched parameters for quantification. The T1/PD combination image was acquired with the same TR as the perfusion images (5936 ms) and was formed by saturation recovery sequence with a 2.0 s saturation time. This saturation time is the same as that of the ASL sequence. The T1 value for blood assumed in the CBF quantification was 1.60 s. The Image reconstruction was performed using IDL based recon code and reconstructed images were stored as DICOM images into the scanner's database.

### Data Preprocessing ASL

The ASL data was processed using the fMRI utility of the Brain Software Library (FSL, Version 5.0.9^[1](#fn01){ref-type="fn"}^). The combined delay image was obtained per participant and non-brain tissue was removed using the Brain Extraction Tool (BET^[2](#fn02){ref-type="fn"}^, part of FSL). The brain extracted combined delay maps were normalized to Montreal Neurological Institute (MNI) standard space using an Echo Planar Image (EPI) template from the Statistical Parametric Mapping (SPM8) toolbox, standard space using linear registration (FMRIB Linear Image Registration Tool^[3](#fn03){ref-type="fn"}^, part of FSL). The concatenated transformation matrix of the transit delay maps was then applied to the uncorrected flow maps, the transit time corrected flow maps and the transit delay maps to spatially normalize the data to the EPI template.

The normalized ASL images were smoothed with a 5 mm FWHM Gaussian kernel using a dilated 2 mm brain extracted MNI mask (FSLUtils ^[4](#fn04){ref-type="fn"}^, part of FSL). Due to the low intrinsic signal to noise level of ASL, we have decided to apply spatial smoothing in order to improve detection of group differences since spatial normalization intrinsically includes a certain degree of smoothing. Furthermore, some statistical procedures require smoothed data.

### ASL Group Comparisons

All of the following analysis were executed for the corrected, uncorrected and delay maps separately. The cognitive groups were compared using voxel-wise permutation-based testing (Randomize^[5](#fn05){ref-type="fn"}^, part of FSL), with threshold-free cluster-enhancement correction for multiple comparisons applied ([@B38]) and *p* \< 0.05 considered significant. Five thousand permutations were executed per contrast. The MNI 2 mm brain extracted mask was used during randomization for masking of non-brain voxels. A triple *T*-test design was administered with age and gender as non-explanatory co-regressors ([@B26]). Age was defined as the difference in days between the date of birth and the day of scanning.

### ASL-Based Clinicoradiologic Correlations

For each group, Spearman rho correlations were calculated between the Shapes test and the Verbal fluency test and the corrected, uncorrected and delay maps separately using MATLAB version R2017b, to assess clinicoradiologic correlations in each group.

Group differences in correlation between the neuropsychological scores on the Shapes test, and the Verbal fluency test and the ASL response were investigated with a continuous-covariate-interaction-design^[6](#fn06){ref-type="fn"}^.

To see whether the relationship between the ASL response and the neuropsychological test differed between groups, a triple *T*-test with 6 contrasts was carried out per neuropsychological test, representing all possible differences in scores between groups. The cognitive groups were once again compared using voxel-wise permutation-based testing with 5000 permutations per contrast (Randomize; see text footnote^5^, part of FSL), threshold-free cluster-enhancement correction for multiple comparisons applied ([@B38]) masked with the 2 mm brain extracted mask and *p* \< 0.05 considered significant.

CVR CO~2~
---------

### CO~2~ Admission

The CO~2~ administration protocol is described in more details elsewhere ([@B33]). In short, the CO~2~ challenge consisted of 9 min of CO~2~ admission via a nasal cannula. A concentration of 7% CO~2~ mixed with synthetic air was given with the sequence 1 min OFF, 2 min ON, 2 min OFF, 2 min ON, 2 min OFF. Subjects were asked to breathe normally through the nose. During admission, EPI covering the entire brain was acquired using a 32 multi-channel coil with the following parameters: FOV = 28.5 cm, 96 × 96 matrix, voxel size of 2.9688 × 2.9688 × 3 mm^3^, echo times of 30 ms, repetition time of 3000 ms, 45 repetitions.

### Preprocessing MRI

The CO~2~ data was processed using FSL Version 5.0.9 ([@B23]). The functional sequences were realigned to the mean per sequence to correct for motion effects ([@B22]) and non-brain tissue was removed using the Brain Extraction Tool ([@B37]). Individual structural images were skull-stripped and co-registered to a standard 2 mm MNI brain extracted by employing standard FLIRT procedure ([@B22]).

The transformation matrices from the functional to the subject space were calculated using the mean functional images per subject with the epi_reg script provided by FSL ([@B22]).

White matter (WM) and Cerebral Spinal Fluid (CSF) masks were calculated as follows; WM and CSF were segmented from the individual high-resolution 3D images with FMRIB's automated segmentation tool ([@B46]). The resulting masks were compared with *a priori* tissue mask containing an average of MRI images of 152 subjects, as provided by the MNI and hereafter binarized with a threshold of 0.6 in subject space. For both WM and CSF masks, a mean time series of the functional data within the tissue specific mask was calculated and used to filter out the WM and CSF effects, and additionally the motion correction parameters with the FSL command-line tool. Smoothing was applied to the denoised functional data with a 5 mm FWHM Gaussian kernel using the brain-extracted mask of the mean functional image. As for the ASL data, we applied spatial smoothing to reduce the effects of noise on the group analysis. In addition, to ensure an analysis pipeline as similar as possible for both the CO2 and ASL data, the application of spatial smoothing was appropriate. In this manner, comparability of the two techniques was optimized.

The denoised, smoothed functional CO~2~ data was normalized to the standard 2 mm MNI brain extracted template by usage of the FMRI Expert Analysis Tool v6.00, with the same normalization method employed as described earlier. In addition, a high pass filter of 270 s was applied to the data and pre-whitening was performed with FMRIB's Improved Linear Model.

### First-Level Analysis CVR CO~2~

The pre-processed functional CO~2~ sequences were used to carry out the first-level analysis. A standard first-level FSL pipeline was employed to fit the CO~2~ response to the subjects' response. Convolution of the ON/OFF response of the CO~2~ admission was done using a simple square wave form, correcting for wash-in and wash-out effects in a straightforward and effective way ([@B30]; [@B33]). The square wave form has shown to approximately model the increase and decrease of CO~2~ levels during administration ([@B33]).

### CVR CO~2~ Response Group Comparisons

To investigate whether there was a difference in CVR CO~2~ response between the SS, V and PP group, an *F*-test design was applied. To further specify which groups differentiated from one another on the CO~2~ response, a triple *T*-test design was executed with a standard higher-level FSL pipeline.

### CVR CO~2~ Response-Based Clinicoradiologic Correlations

Spearman rho correlation was computed between the Shapes test and Verbal fluency test and CO~2~ maps for each group, using MATLAB version R2017b. The relationship between the neuropsychological scores (the Shapes and the Verbal fluency tests) and the CVR CO~2~ response was investigated by a three group with continuous-covariate-interaction-design see text footnote^6^. To see whether the relationship between the CVR CO~2~ response and the neuropsychological test differed between groups, triple *T*-tests with 6 contrasts were carried out per neuropsychological test, covering all potential group-differences.

Results
=======

Demographic Data and Neuropsychological Test Scores
---------------------------------------------------

No statistically significant group differences were found in demographic variables (age and gender). Neuropsychological scores at baseline did not differ between the three groups (see [Table 1](#T1){ref-type="table"}).

###### 

Demographical and neuropsychological data of the included study groups of the SS, V, and PP participants.

                         Stable-Stable   Variable   Progressive-Progressive   *P*-value                                                                            
  ---------------------- --------------- ---------- ------------------------- ----------- ------- -------- --------------------------- ------------- ------------- -------------
  Gender (male)          11 M                       13 M                                  10 M             *p* = 0.967, η^2^ = 0.000   *p* = 0.883   *p* = 0.900   *p* = 1.00
  Age (years)            78.86           4.122      78.96                     4.074       78.19   2.158    *p* = 0.728, η^2^ = 0.091   *p* = 0.994   *p* = 0.727   *p* = 0.810
  Shapes                 34.75           2.609      33.06                     4.007       34.32   2.476    *p* = 0.128, η^2^ = 0.053   *p* = 0.134   *p* = 0.341   *p* = 0.894
  Verbal fluency         18.00           4.625      17.85                     4.912       17.59   4.896    *p* = 0.850, η^2^ = 0.004   *p* = 0.878   *p* = 0.997   *p* = 0.866
  Trail A/B              2.53            0.814      2.71                      0.982       2.72    0.668    *p* = 0.668, η^2^ = 0.011   *p* = 0.710   *p* = 0.997   *p* = 0.714
  MMSE                   28.58           1.283      28.39                     1.784       28.36   1.002    *p* = 0.959, η^2^ = 0.001   *p* = 0.992   *p* = 0.979   *p* = 0.956
  IADL                   8.54            0.779      8.15                      0.364       8.64    1.529    *p* = 0.128, η^2^ = 0.053   *p* = 0.276   *p* = 0.154   *p* = 0.938
  HAD                    5.54            3.623      7.73                      4.837       8.50    5.087    *p* = 0.076, η^2^ = 0.066   *p* = 0.184   *p* = 0.813   *p* = 0.080
  Digit span forward     7.96            1.732      9.03                      2.243       8.23    1.974    *p* = 0.119, η^2^ = 0.054   *p* = 0.126   *p* = 0.326   *p* = 0.895
  Digit span backward    5.25            1.511      5.88                      1.691       4.86    1.754    *p* = 0.079, η^2^ = 0.065   *p* = 0.338   *p* = 0.073   *p* = 0.710
  Corsi block forward    7.42            1.316      7.55                      1.394       7.27    1.352    *p* = 0.766, η^2^ = 0.007   *p* = 0.934   *p* = 0.747   *p* = 0.932
  Corsi block backward   6.83            0.963      6.42                      1.251       6.41    1.260    *p* = 0.356, η^2^ = 0.027   *p* = 0.400   *p* = 0.999   *p* = 0.443
  Boston naming          19.21           1.021      19.27                     1.153       19.27   0.767    *p* = 0.967, η^2^ = 0.001   *p* = 0.970   *p* = 1.00    *p* = 0.975
  Ghent overlapping      4.96            0.204      4.94                      0.348       5.00    0.000    *p* = 0.682, η^2^ = 0.010   *p* = 0.958   *p* = 0.659   *p* = 0.842
  CERAD                  10.83           0.381      10.82                     0.528       10.73   0.767    *p* = 0.790, η^2^ = 0.006   *p* = 0.995   *p* = 0.831   *p* = 0.803
  Digit-symbol-coding    55.38           12.521     55.18                     8.658       51.95   11.090   *p* = 0.466, η^2^ = 0.020   *p* = 0.997   *p* = 0.515   *p* = 0.523

No significant group-differences were found on age, gender or any of the neuropsychological tests.

ASL Group Comparisons
---------------------

The quantitative CBF and CVR values of the included study groups are shown in [Table 2](#T2){ref-type="table"}. Comparison of the perfusion maps between the three groups demonstrated a significantly higher perfusion value in both the corrected and uncorrected maps of the PP group as compared to the V group. As can be seen in [Figure 1](#F1){ref-type="fig"}, these regions largely overlap in both perfusion maps. Differences within the corrected flow maps between the groups can be clearly seen within the parietal regions, including the precuneus but also in temporal and frontal regions. Example corrected perfusion maps from the different groups emphasize the hypoperfusion within the precuneus of the V group once more, while in the example maps of both the SS and PP group perfusion in these regions remains preserved ([Figure 2](#F2){ref-type="fig"}).

###### 

Quantitative CBF and CVR values of the included study groups of the SS, V, and PP participants.

                       Stable-stable   Variable     Progressive-progressive                              
  -------------------- --------------- ------------ ------------------------- ------------ ------------- ------------
  **ASL CBF maps**     36.180118       16.936111    34.896856                 15.598446    34.043468     15.517011
  **ASL Delay maps**   1535.553350     408.553332   1535.864498               410.159331   1523.346373   426.743474
  **CO~2~ CVR maps**   9.490050        25.768619    9.131709                  25.240867    9.982506      25.039040

![Group differences in arterial spin labeling (ASL) perfusion measures. The progressive-progressive (PP) group shows regional higher perfusion values as compared to the variable (V) group in both the uncorrected and corrected flow maps. This difference can be clearly seen in the corrected flow maps in the parietal regions including the precuneus. The PP group similarly shows significantly higher perfusion than the V group within the parietal lobe, but also temporal and frontal regions.](fnagi-11-00019-g001){#F1}

![Example ASL perfusion maps of stable-stable (SS), V, and PP group separately. The examples of the V group demonstrate a lower perfusion within the precuneus, while in the example maps of both the SS and PP group perfusion in these regions remains relatively preserved.](fnagi-11-00019-g002){#F2}

Group comparison of the uncorrected maps demonstrates a significantly higher perfusion in PP compared to the V group that was diffusely present in several neocortical areas. No other significant group differences were found in respect to ASL delay maps.

ASL-Based Clinicoradiologic Correlations
----------------------------------------

The Spearman correlation maps per group reveal distinct patterns as a function of the group of reference only for the Shapes test. In SS group, negative associations between ASL values and Shapes test performances were found in most areas with the exception of the frontal and cerebellar regions ([Figure 3](#F3){ref-type="fig"}). A similar predominance of negative correlations was observed in PP group. Interestingly, the Spearman rho maps of the V group show prominent positive correlations in areas that show negative rho values in the SS group. Group comparisons showed significant differences in ASL-Shapes test correlation between the V and SS group in right temporo-parietal junction and superior parietal lobule ([Figure 4A](#F4){ref-type="fig"}).

![Spearman's rho correlation maps between ASL values and the Shapes test performance. A predominance of negative associations was found in the SS group, with positive correlations residing in the frontal and cerebellar regions. The PP group also displays a negative association in most of the brain areas especially in regions surrounding the ventricles. Interestingly, the Spearman rho maps of the V group show global prominent positive correlations in areas that show negative rho values in the SS group, residing largely in the medial part of the brain.](fnagi-11-00019-g003){#F3}

![Group differences in the relation between neuroimaging parameters (ASL, CVR-CO~2~) and Shapes test performance. **(A)** Stronger positive relationship in the tempo-parietal junction and superior parietal lobe in V group as compared to the SS group. **(B)** Stronger positive correlation in both the PP and SS group as compared to the V group in right peri-sylvian and superior areas.](fnagi-11-00019-g004){#F4}

CVR CO~2~ Response Group Comparisons
------------------------------------

The *F*-test demonstrated that there were significant differences between groups on the CO~2~ response (data not shown). The *T*-tests demonstrated a significantly stronger CO~2~ response of the PP group in left parietal areas as compared to the V group ([Figure 5](#F5){ref-type="fig"}). No regional differences in CO~2~ response were found between the other groups.

![Differences in the cerebral vasoreactivity to CO~2~ (CVR CO~2~) response between groups. The PP group shows a stronger CVR CO~2~ response in comparison to the V group in the superior left parietal lobe.](fnagi-11-00019-g005){#F5}

CVR CO~2~ Response-Based Clinicoradiologic Correlations
-------------------------------------------------------

No group differences were identified in respect to the association between Verbal Fluency test performances and CVR CO~2~ maps. [Figure 6](#F6){ref-type="fig"} shows the Spearman's rho maps referring to the relationship between the CVR CO~2~ maps and Shapes test. The SS and PP groups display a fairly similar pattern of correlation, showing a positive relationship between the CVR CO~2~ response and Shapes test performance in medial brain regions with negative rho values in frontal cortex. In contrast, the V group demonstrates an opposite pattern with negative medial correlations, along with positive associations represented in parietal areas. CVR CO~2~-Shapes test correlation was significantly higher in both the SS and PP groups compared to the V group in the right insular region and superior perisylvian areas ([Figure 4B](#F4){ref-type="fig"}).

![Regional Spearman's rho correlation maps between CVR CO~2~ response and the Shapes test performance. Both the SS and PP groups displayed a fairly similar pattern of correlation, showing a positive relationship in the medial brain, with a frontal display of negative rho values. In contrast, the V group demonstrates negative correlations in medial brain regions, along with positive ones in parietal areas.](fnagi-11-00019-g006){#F6}

Discussion
==========

To our knowledge, this is the first study combining ASL perfusion and CVR CO~2~ measures with a longitudinal follow-up of cognitive abilities in elderly individuals with preserved neuropsychological performances at baseline. Our data indicate that both imaging measures show a subtle decrease in cases with the first signs of cognitive instability (V group) suggesting the presence of cerebral hypoperfusion and decreased cerebrovascular reactivity mainly in parietal and fronto-temporal association areas in this particular group. Importantly, cases with continuous cognitive decline (PP group) at high risk for MCI transition display an increase of both parameters in the same areas. The distinct profile of cognitively unstable cases compared to the two other groups of healthy controls is also documented by our clinicoradiologic correlations.

Early ASL-MRI contributions showed both hypoperfusion and hyperperfusion areas in MCI and AD cases stressing the brain efforts to compensate lesion invasion and cognitive loss. Despite controversial observations, two main patterns have been identified. A marked hypoperfusion in posterior cingulate cortex, precuneus and parietal cortex is already present in MCI cases ([@B24]; [@B13]). In AD, a global decrease in blood flow is observed as compared to healthy controls, but region specific decrease in perfusion have also been detected ([@B5]). The hypoperfusion areas become more diffuse in clinically overt AD as to MCI including temporo-occipital and parieto-occipital cortices as well as orbitofrontal cortex ([@B2]; [@B4]; [@B18]; [@B5]; [@B9]; [@B21]). A hyperperfusion in hippocampus and basal ganglia was reported both in MCI and AD cases but also in non-symptomatic high risk APOE 𝜀4 carriers ([@B1]; [@B13]; [@B18]; [@B15]). ASL data on cognitively preserved elderly persons are very scarce. They showed both hypoperfusion in frontal, parietal and cingulate areas but also a strong negative association between diffuse hyperperfusion in neocortical association areas and cognitive performances in APOE 𝜀4 carriers pointing to the presence of compensatory mechanisms explained by a pathological elevation of neural activity, inflammation or increased blood supply through vascular dilation or increased vascular density. In a longitudinal study, we first reported that decreased ASL values in posterior cingulate cortex were associated with subtle cognitive changes in cognitively intact elderly subjects ([@B44]). More recently, ASL perfusion rates in medial frontal and anterior cingulate cortex predicted cognitive performances in a 4-year follow up of healthy elders ([@B14]). Our longitudinal findings in carefully selected healthy controls shed some light into subtle changes of brain perfusion in the very initial stages of cognitive instability. In agreement with the observations made in MCI and AD cohorts, we found a subtle decrease of ASL values mainly in parietal cortex and precuneus (and to a lesser degree in temporal and frontal cortex) that is already present at inclusion in cases with cognitive fluctuations over a subsequent 3-year follow-up. PP cases showed increased ASL values in the same areas at inclusion (even higher than those in the SS group yet non-significant), but they deteriorate continuously suggesting that hyperperfusion in these areas is not an efficient defense against the neurodegenerative process. This idea is further supported by the CVR CO~2~ measures showing a slightly decreased brain cerebrovascular reactivity in V cases with a steady increase in PP cases mainly in parietal areas. As for ASL, early studies using BOLD functional MRI documented CVR CO~2~ decrease mainly in temporal, parietal and posterior cingulate areas in AD cases but also in hippocampus in MCI cases ([@B11]; [@B45]; [@B33]). Taken together, these data imply the presence of an inverted U-shape pattern of regional blood flow and cerebral vasoreactivity in parietal cortex in old age that might predict subsequent cognitive fate. In fact, the cerebral vasoreactivity to CO~2~ slightly decreased in control cases with fluctuant cognitive performances, shows a compensatory increase in these with continuous decline prior to the MCI status before a marked decrease in MCI and AD cases. The clinico-radiologic correlations between Shapes test measures, an indicator of visual working memory, and both ASL and CVR CO~2~ data point further to the different behavior of V cases compared to both PP and SS cases. Similar differences were not observed in respect to Verbal fluency possibly because of the absence of significant associations between cognitive performance and imaging parameters for this test.

The biological significance of these observations remains matter of debate. Cortical hypometabolism is a core feature in preclinical AD and is associated with worst clinical evolution ([@B16]; [@B8]; [@B27]). However, increased glucose metabolism was also reported in amyloid-negative amnestic MCI cases and is thought to reflect compensatory mechanism to the neuronal damage occurring early in the disease process (for review see [@B3]). Whether the hypoperfusion observed mainly in parietal and posterior cingulate areas is causally related to AD or only its epiphenomenon remained unclear. Without bringing a definite answer, our data suggest that parietal and posterior cingulate cortex hypoperfusion is an early event in totally asymptomatic cases with fluctuations in cognitive performances within the normal range. It has been long thought that the hyperperfusion patterns in clinically overt AD and MCI may reflect increased neural activity as part of compensatory mechanisms aiming to counterbalance the cognitive decline. Alternatively, they may reflect alteration in brain vasculature due to increased angiogenesis or increased cerebrovascular reactivity possibly reflecting dysregulation of the neurovascular unit without any significant gain in terms of cognitive performance (for review see [@B48]; [@B36]). The present observations combining ASL and CVR CO~2~ measures clearly support the second hypothesis. In fact, our PP cases displayed higher ASL and CVR CO~2~ values in parietal areas prior to their cognitive decline. These results parallel the findings of [@B48] in APOE 𝜀4 healthy carriers who reported a negative association between verbal memory function and ASL values in medial fronto-temporal and parietal cortex.

Strengths of the present study include the 3-year neuropsychological follow-up, careful exclusion of MCI and incipient AD cases, and combined use of ASL and CVR-CO~2~ techniques. Several limitations should, however, be considered when interpreting these data. In the absence of longer follow-up, the cognitive fate of PP and V cases remains uncertain. No CSF measures of tau and Aβ protein were available in this work so that the real extent of AD pathology remains unknown. Most importantly, the small sample size may mask subtle imaging differences between SS and PP as well as V cases. Future studies including PET amyloid and tau assessment of AD pathology as well as longer follow-up are warranted to define better the role of cerebrovascular mechanisms in the prediction of cognitive deterioration in asymptomatic elderly individuals.
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